Helicobacter pylori infection and serum homocysteine in hemodialysis patient

Life Science Journal

Volumn 9, Issue 4, 2012, Pages 3696-3702

  Rafiean Kopaei, Mahmoud ^a   Baradaran, Azar ^a   Maghsoudi, Ahmad Reza ^a   Ghobadi, Shamin ^a   Nasri, Hamid ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Helicobacter pylori; Hemodialysis; Homocysteine; Renal failure

Indexed keywords

HELICOBACTER; HELICOBACTER PYLORI;

EID: 84877089354     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Nasri H. Aggravation of anemia by helicobacter pylori infection in maintenance hemodialysis patients. Pak J Nutr 2006; 5(2): 172-5.
2. Nasri H. The association between helicobacter pylori infection and body mass index in hemodialysis patients. Acta Facultatis Medicae Naissensis 2006; 23(3): 129-33.
3. Asl MK, Nasri H. Prevalence of Helicobacter pylori infection in maintenance hemodialysis patients with non-ulcer dyspepsia. Saudi J Kidney Dis Transpl. 2009; 20(2): 223-6.
4. Nasri H. Helicobacter pylori infection and its relationship to plasma magnesium in hemodialysis patients. Bratisl Lek Listy. 2007; 108(12): 506-9.
5. Nasri H. Baradaran A. The influence of serum 25-hydroxy vitamin Dlevels on Helicobacter Pylori Infections in patients with end-stage renal failure on regular hemodialysis. Saudi J Kidney Dis Transpl 2007; 18(2): 215-9.
6. Baradaran A. Nasri H. Helicobacter Pylori IgG Specific antibodies in association with serum albumin in maintenance hemodialysis patients. Pak J Nutr 2005; 4(4): 265-9.
7. Baradaran A, Nasri H. Association of Helicobacter pylori IgG antibody with various demographic and biochemical parameters in kidney transplant recipients. Saudi J Kidney Dis Transpl. 2011; 22(6): 1115-20.
8. Baradaran A, Nasri H. Helicobacter pylori IgG antibodies in association with secondary hyperparathyroidism in end-stage renal failure patients undergoing regular hemodialysis. Arch Med Sci 2005; 1, 3: 148-151
9. Baradaran A. Nasri H. Correlation of serum leptin with circulating antihelicobacter pylori IgG antibodies in end-stage renal failure patients on regular hemodialysis. Pak J Nutr 2005; 4(6): 389-92.
10. Blaser MJ. Helicobacter pylori: Its role in disease. Clin Infect Dis 1992; 15: 386-93.
11. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-9.
12. Patel P, Mendall MA, Carrington D, Strachan D P, Leatham E, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995 Sep 16; 311(7007): 711-714.
13. Blakeston C, Seymour CA, Camm AJ. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary disease and cardiovascular risk factors. BMJ 1995; 311: 711-4.
14. Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. Aprospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.
15. Ubbink J, Vermaak W, Van der Merwe A, Becker P. Vitamin B12, vitamin B6 and folate nutritional status in men with hyperhomocysteinemia. A m J Clin Nutr 1993; 57: 47-53.
16. Kaptan K, Beyan C, Ural AU, Cetin T, Avcu F, Gulsen M, Finci R, Yalcin A. Helicobacter pylori-I sit anovel causative agent in vita-min B12 deficiency? Arch Intern Med 2000; 160: 1349-53.
17. Carmel R, Johnson CS. Racial patterns in pernicious anemia: Early age at onset and increased frequency of intrinsic-factor antibody in black women. N Engl J Med 1978; 298: 647-50.
18. Serin E, Gümürdülü Y, Ozer B, Kayaselcuk F, Yilmaz U, Kocak R. Impact of Helicobacter pylori on the development of vitamin B12 deficiency in the absence of gastric atrophy. Helicobacter 2002; 7: 337-41.
19. Sung JJ, Sanderson JE. Hyperhomocysteinemia, Helicobacter pylori and coronary heart disease. Heart 1996; 76: 305-7.
20. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathology. 2013; 2(1): 20-27.
21. Tolouian R, Hernandez GT. Prediction of Diabetic Nephropathy: The need for asweet biomarker. J Nephropathology. 2013; 2(1): 4-5.
22. Rouhi H, Ganji F. Effect of N-acetyl cysteine on serum Lipoprotein (a) and proteinuria in type 2 diabetic patients. J Nephropathology. 2013; 2(1): 61-66.
23. Moudd SH, Levy HL, Skovby F. Disorders of transsulfuration In: Scriver CR, Beaudet AL, Sly W S, Valle D, ed. The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, 1989; 693-774.
24. Ghorbani A, Ehsanpour A, Roshanzamir N, Omidvar B. Alterations in antibiotic susceptibility ofurinary tract infection pathogens. J Nephropathology. 2012; 1(1): 43-48.
25. Karimifar M. Deep vein thrombosis in combination with granulomatosis with polyangiitis (Wegener's). J Nephropathology. 2012; 1(1): 57-58.
26. Mubarak M, Collapsing focal segmental glomerulosclerosis: increasing the awareness. J Nephropathology. 2012; 1(2): 77-80.
27. Mohammadi Torbati P. Focal segmental glomerulosclerosis; collapsing variant. J Nephropathology. 2012; 1(2): 87-90.
28. Ardalan MR, Samadifar Z, Vahedi A. Creatine monohydrate supplement induced interstitial nephritis. J Nephropathology. 2012; 1(2): 117-120.
29. Ghorbani A, Rafieian-Kopaie M, Nasri H. Lipoprotein (a): More than abystander in the etiology of hypertension? Astudy on essential hypertensive patients not yet on treatment. J Nephropathology. 2013; 2(1): 67-70.
30. Assadi F. Psychological impact of chronic kidney disease among children and adolescents: Not rare and not benign. J Nephropathology. 2013; 2 (1): 1-3.
31. Galesic K, Ljubanovic D, Horvatic I. Tratment ofrenal manifestations of ANCA-associated Vasculitis. J Nephropathology. 2013; 2(1): 6-19.
32. Shakeel Sh, Mubarak M, Kazi JI, Jafry N, Ahmed E. Frequency and clinicopathological characteristics of variants of primary focal segmental glomerulosclerosis in adults presenting with nephrotic syndrome. J Nephropathology. 2013; 2(1): 28-35.
33. Spasovski D, Latifi A, Marina N, Calovski J, Kafedziska I, Božinovski G, et al. Symmetric dimethyl arginine and N-acetyl-β-Dglucosaminidase lysosimyria of proximal renal tubules as atarget for nephrotoxicity in patients with rheumatoid arthritis treated with disease modifying antirheumatic drugs. J Nephropathology. 2013; 2(1): 36-52.
34. Seif EI, Ibrahim EA, Elhefnawy NG, Salman M I. Histological patterns of idiopathic steroid resistant nephrotic syndrome in Egyptian children: Asingle centre study. J Nephropathology. 2013; 2 (1): 53-60.
35. Rafieian-Kopaei M, Nasri H, Nematbakhsh M, Baradaran A, Gheissari A, Rouhi H, et al. Erythropoietin ameliorates genetamycin-induced renal toxicity: Abiochemical and histopathological study. J Nephropathology. 2012; 1(2): 109-116.
36. Tavafi M. Inhibition of gentamicin-induced renal tubular cell necrosis. J Nephropathology. 2012; 1(2): 83-86.
37. Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathology. 2012; 1(2): 81-82.
38. Boag JT. Basic truths in optimal hemodialysis, dialysis & transplantation. Dialysis & Transplantation 1994; 23(11): 636.
39. Baradaran A, Behradmanesh S, Nasri H. Association of body mass index and serum vitamin Dlevel in healthy Iranian adolescents. Endokrynol Pol. 2012; 63(1): 29-33.
40. Perna AF, Violetti E, Lanza D, Sepe I, Bellinghieri G, Savica V, et al. Therapy of hyperhomocysteinemia in hemodialysis patients: Effects of Folates and N-Acetylcysteine. Ren Nutr. 2012 Jan 6.
41. Nasri H. Apositive correlation of serum homocysteine with leptin in maintenance hemodialysis patients. Arch Med Sci 2006; 2, 3: 185-189.
42. Bradran A. Nasri H. Association between white blood cell count and levels of serum homocysteine inend-stage renal failure patients treating with hemodialysis. J Ayub Med Coll Abbottabad. 2006; 18(1): 22-6.
43. Nasri H. Infulence of serum homocysteine on platelet count in stable hemodialysis patients. Pak J Physiol 2006; 2(2): 5-7.
44. Eikelbloom JW, Lonn E, Genest J. Homocysteine and car diovascular disease: acritical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363-75.
45. Nasri H, Baradaran A. Association of serum homocysteine with anemia in maintenance hemodialysis patients. Pakistan Journal of Nutrition 2005; 4(6): 414-7.
46. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (32; 1998 SUPPL 3): S112-9
47. Sipponen P, Laxen F, Huotari K, Harkonen M. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 2003; 38(12): 1209-16.
48. Aguilera A, Codoceo R, Bajo MA, Diez JJ, del Peso G, Pavone M. Helicobacter pylori infection: anew cause of anorexia in peritoneal dialysis patients. Perit Dial Int 2001; 21(Suppl 3): S152-6.
49. Rasmi Y, Farshid S, Makhdomi K. Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection. Saudi J Kidney Dis Transpl. 2012; 23(3): 489-92.
50. Huang C, Chen Q, Jiang J, Zhang J, Bao B, Yao X. Gastric metaplasia and Helicobacter pylori infection in hemodialysis patients. Ren Fail. 2012; 34(4): 420-4.
51. Tamura A, Fujioka T, Nasu M. Relation of Helicobacter pylori infection to plasma vitamin B 12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriogra phy. A m J Gastroenterol 2002; 97(4): 861-6.
52. Shuval-Sudai O, granot E. An association between Helicobacter pylori infection and serum vitamin B12 levels in healthy adults. J Clin Gastroenterol 2003; 36(2): 130-3.
53. Dierkes J, Ebert M, Malfertheiner P, Luley C. Helicobacter pylori infection, vitamin B12 and homocysteine. A Review Dig Dis 2003; 44-237: (3)21.
54. Khajehdehi P. Turmeric: Reemerging of aneglected Asian traditional remedy. J Nephropathology. 2012; 1(1): 17-22.
55. Tayebi Khosroshahi H. Short history about renal transplantation program in Iran and the world: Special focus on world kidney day 2012. J Nephropathology. 2012; 1(1): 5-10.
56. Sarari AS, Farraj MA, Hamoudi W, Essawi T A. Helicobacter pylori, acausative agent of vitamin B12 deficiency. J Infect Dev Ctries. 2008 Oct 1; 2(5): 346-9.
57. Tolou-Ghamari Z. Nephro and neurotoxicity, mechanisms of rejection: Areview on Tacrolimus and Cyclosporin in organ transplantation. J Nephropathology. 2012; 1(1): 23-30.
58. Su VC, Shalansky K, Jastrzebski J, Martyn A, L i G, Yeung CK. Parenteral vitamin B12 in macrocytic hemodialysis patients reduced MMA levels but did not change mean red cell volume or hemoglobin. Clin Nephrol. 2011 Apr; 75(4): 336-45.
59. Einollahi B. Are acquired cystic kidney disease and autosomal dominant polycystic kidney disease risk factors for renal cell carcinoma in kidney transplant patients? J Nephropathology. 2012; 1(2): 65-68.
60. Kari J. Epidemiology of chronic kidney disease inchildren. J Nephropathology. 2012; 1(3): 162-163.
61. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic Kidney Disease in Children: Areport from atertiary care center over 11 years. J Nephropathology. 2012; 1 (3): 159-164.
62. Baradaran A. Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathology. 2012; 1(3): 126-129.
63. Sahni N, Gupta KL. Dietary antioxidents and oxidative stress in predialysis chronic kidney patients. J Nephropathology. 2012; 1(3): 134-142.
64. Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: Apediatric experience over 10 years at atertiary care center. J Nephropathology 2012; 1(2): 101-108.
65. Ozer B, Serin E, Gumurdulu Y, Kayaselcuk F, Anarat R, Gur Get al. Helicobacter pylori eradication lowers serum homocysteine level in patients without gastric atrophy. World J Gastroenterol. 2005 May 14; 11(18): 2764-7.
66. Assadi F. The epidemic of pediatric chronic kidney disease: the danger of skepticism. J Nephropathology 2012; 1(2): 61-64.
67. Trimarchi H, Forrester M, Schropp J, Pereyra H, Freixas EA. Low initial vitamin B12 levels in Helicobacter pylori--positive patients on chronic hemodialysis. Nephron Clin Pract. 2004; 96(1): c28-32.
68. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies BMJ 1998; 316: 1130-2.
69. Harker LA, Harlan JM, Ross R. Effect of sulfinpyrazone on homo-cysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res. 1983; 53: 731-9.
70. Nasri H. Hypertension and renal failure with right arm pulse weakness in a 65 years old man. J Nephropathology. 2012; 1(3): 130-133.
71. Sánchez-Niño MD, Ortiz A. Is it or is it not apathogenic mutation? Is it or is it not the podocyte? J Nephropathology. 2012; 1(3): 152-154.
72. Ghorbani A, Rafieian-Kopaie M, Nasri H. Lipoprotein (a): More than abystander in the etiology of hypertension? Astudy on essential hypertensive patients not yet on treatment. J Nephropathology. 2013; 2(1): 67-70.
73. Ardalan MR, Vahedi A. Antiphospholipid syndrome: Adisease of protean face. J Nephropathology. 2013; 2(1): 81-84.
74. Ali A, Al-Windawi S. Tubulointerstitial Lupus nephritis. J Nephropathology. 2013; 2(1): 75-80.
75. Gupta KL, Gupta A. Mucormycosis and Acute Kidney Injury. J Nephropathology. 2012; 1(3): 155-159.
76. Harker LA, Ross R, Slichter SJ, Scott CR. Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976; 58: 731-41.
77. Heinecke JW, Kawamura M, Suzuki L, Chait A. Oxidation of low-density lipoprotein by thiol: Superoxide-dependent and independent mechanisms. J Lipid Res. 1993; 34: 2051-61.
78. Sobala GM, Schorah CJ, Sanderson M, Dixon M F, Tompkins DS, Godwin P, Axon AT. Ascorbic acid in the human stomach Gastroenterology 1989; 97: 357-63.
79. Rathbone BJ, Johnson AW, Wyatt JI, Kelleher J, Heatley RV, Losowsky MS. Ascorbic acid: Afactor concentrated in human gas tric juice. Clin Sci. 1989; 76: 237-41.
80. Lucock MD, Priestnall M, Daskalakis I, Schorah CJ, Wild J, Levene MI. Nonenzymatic degradation and salvage of dietary folate: Physicochemical factors likely to influence bioavailability. Biochem Molec Med. 1995; 55: 43-53.
81. Jalalzadeh M, Ghadiani MH, Mousavinasab N. Association between Helicobacter Pylori infection and body mass index, before and after eradication ofinfection in hemodialysis patients. J Nephropathology. 2012; 1(3): 170-176.